Drugs, ligation or both for the prevention of variceal rebleeding?
Schepke
Michael
M
Department of Internal Medicine, Gastroenterology and Hepatology, Helios Clinic, 53721 Siegburg, Germany. michael.schepke@helios-kliniken.de
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008026:Ligation; D055502:Secondary Prevention; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents